Filing Flows › Charles River Laboratories International (CRL) › Q3 2025
Charles River Laboratories International (CRL) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 5, 2025
Charles River Laboratories International (CRL) reported revenue of $1.0B for the third quarter 2025 (Q3 2025), -0.5% from a year earlier and -3% from the quarter before. Operating margin was 13.3%, net earnings $54.4M (5.4% of revenue).
Charles River Laboratories International, Q3 2025: revenue $1.0B (-0.5% year over year), operating margin 13.3%, net earnings $54.4M, operating cash flow $214M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0B | -3% | -0.5% |
| Operating profit | $134M | +34% | +14% |
| Net earnings | $54.4M | +4% | -22% |
| Operating cash flow | $214M | +5% | -15% |
| Free cash flow | $178M | +5% | -16% |
What changed
Revenue was $1.0B in Q3 2025, roughly flat year over year and down 3% from the previous quarter. DSA was the largest line at 60% of revenue. DSA lost $0.01B year over year (down 2%), 293% of the total change.
Operating profit was $0.13B, a 13.3% margin (up 1.7 points year over year). Total costs fell 2% while revenue was flat. The fastest-growing cost line was Other operating costs (+2040%). Net earnings were $0.05B, down 22% year over year. The effective tax rate was 36.3%.
Operating cash flow was $0.21B (down 15% year over year), 385% of net income including minority interests. Non-cash charges added back $0.09B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items added $0.05B. Capital expenditures of $0.04B left free cash flow of $0.18B.
Questions
What was Charles River Laboratories International's revenue in the third quarter 2025?
Charles River Laboratories International (CRL) reported revenue of $1.0B for the third quarter 2025 (Q3 2025), -0.5% from a year earlier and -3% from the quarter before.
Was Charles River Laboratories International profitable in the third quarter 2025?
Operating profit was $134M (13.3% of revenue) and net earnings $54.4M.
Source: Charles River Laboratories International 10-Q on SEC EDGAR.